Skip to main content
Clinical Trials/NCT03101098
NCT03101098SuspendedNot Applicable

Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus: A Randomized Controlled Trial

Kangbuk Samsung Hospital1 site in 1 country54 target enrollmentStarted: April 10, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
54
Locations
1
Primary Endpoint
Operative blood loss

Study Overview

Brief Summary

This randomized trial is aimed to investigate the role of retroperitoneal TLH in enlarge uterus.

Detailed Description

Laparoscopic hysterectomy is one of the most common gynecologic surgeries worldwide. Generally, in total laparoscopic hysterectomy (TLH), uterine arteries are coagulated or transected close to the uterus, alongside the cervix, like surgical technique of a conventional total abdominal hysterectomy. Recently, several studies showed that ligation of uterine artery where it originates from the internal iliac artery during TLH (so-called "retroperitoneal TLH") is effective for reducing blood loss. However, the application of this technique to clinical practice have not been well investigated in terms of its efficacy and safety. Moreover, most of the previous studies on retroperitoneal TLH were small case series or retrospective comparative studies with conventional TLH. Therefore, the investigators conducted this randomized trial to investigate the role of retroperitoneal TLH in enlarge uterus.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •absence of pregnancy at the time of presentation
  • •uterine volume between 12 and 18 weeks of gestation by pelvic examination
  • •appropriate medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2)

Exclusion Criteria

  • •any suggestion of malignant uterine or adnexal diseases
  • •any major medical comorbidities or psychiatric illnesses, which could affect follow-up and/or compliance
  • •an inability to understand and provide written informed consent.

Arms & Interventions

Retroperitoneal hysterectomy

Experimental

In subjects allocated to the experimental group, which the uterine vessels were ligated where it originates from the internal iliac artery,

Intervention: Retroperitoneal liagation of uterine artery (Procedure)

Classical hysterectomy

Active Comparator

The operative technique of classical total laparoscopic hysterectomy (TLH) performed in the control group was comparable to that of retroperitoneal TLH, except for one that coagulation and transection of uterine artery was achieved using an energy device alongside the cervix

Intervention: Classical ligation of uterine artery (Procedure)

Outcomes

Primary Outcomes

Operative blood loss

Time Frame: Operation day

Operative blood loss was calculated by the anesthesiology unit as the difference between the total amount of suction and irrigation plus the difference between the total gauze weight before and after surgery.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kangbuk Samsung Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Taejong Song

Professor

Kangbuk Samsung Hospital

Study Sites (1)

Loading locations...

Similar Trials